Table of Contents Author Guidelines Submit a Manuscript
Journal of Osteoporosis
Volume 2018, Article ID 8726456, 7 pages
https://doi.org/10.1155/2018/8726456
Review Article

“Omics” Signatures in Peripheral Monocytes from Women with Low BMD Condition

Division of Molecular Immunodiagnostics, National Institute for Research in Reproductive Health, ICMR, J. M. Street, Parel, Mumbai 400012, India

Correspondence should be addressed to M. Ikram Khatkhatay; ni.ser.hrrin@iyatahktahk

Received 18 November 2017; Accepted 12 February 2018; Published 18 March 2018

Academic Editor: Merry Jo Oursler

Copyright © 2018 Bhavna Daswani and M. Ikram Khatkhatay. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. G. Raisz, “Physiology and pathophysiology of bone remodeling,” Clinical Chemistry, vol. 45, no. 8, pp. 1353–1358, 1999. View at Google Scholar · View at Scopus
  2. G. A. Rodan, L. G. Raisz, and J. P. Bilezikian, Pathophysiology of Osteoporosis, J. P. Bilezikian, L. G. Raisz, and G. A. Rodan, Eds., Principles of Bone Biology, Academic Press, USA, 2nd edition, 2000.
  3. H. Takayanagi, “Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems,” Nature Reviews Immunology, vol. 7, no. 4, pp. 292–304, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Salamanna, M. Maglio, G. Giavaresi, S. Pagani, R. Giardino, and M. Fini, “In vitro method for the screening and monitoring of estrogen-deficiency osteoporosis by targeting peripheral circulating monocytes,” Age (Dordrecht Netherlands), vol. 37, p. 9819, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Jevon, T. Hirayama, M. A. Brown et al., “Osteoclast formation from circulating precursors in osteoporosis,” Scandinavian Journal of Rheumatology, vol. 32, no. 2, pp. 95–100, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. M. E. Cohen-Solal, A. M. Graulet, M. A. Denne, J. Gueris, D. Baylink, and M. C. De Vernejoul, “Peripheral monocyte culture supernatants of menopausal women can induce bone resorption: Involvement of cytokines,” The Journal of Clinical Endocrinology & Metabolism, vol. 77, no. 6, pp. 1648–1653, 1993. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Zhou, H.-W. Deng, and H. Shen, “Circulating monocytes: an appropriate model for bone-related study,” Osteoporosis International, vol. 26, no. 11, pp. 2561–2572, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. G. C. Nicholson, M. Malakellis, F. M. Collier et al., “Induction of osteoclasts from CD14-positive human peripheral blood mononuclear cells by receptor activator of nuclear factor κB ligand (RANKL),” Clinical Science, vol. 99, no. 2, pp. 133–140, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. S. M. B. Tinkler, J. E. Linder, D. M. Williams, and N. W. Johnson, “Formation of osteoclasts from monocytes during 1α-OH Vit D-stimulated bone resorption in mice,” Journal of Anatomy, vol. 133, no. 3, pp. 389–396, 1981. View at Google Scholar · View at Scopus
  10. J. M. W. Quinn, J. O. Mc Gee, and N. A. Athanasou, “Cellular and hormonal factors influencing monocyte differentiation to osteoclastic bone-resorbing cells,” Endocrinology, vol. 134, no. 6, pp. 2416–2423, 1994. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Fujikawa, J. M. W. Quinn, A. Sabokbar, J. O. McGee, and N. A. Athanasou, “The human osteoclast precursor circulates in the monocyte fraction,” Endocrinology, vol. 137, no. 9, pp. 4058–4060, 1996. View at Publisher · View at Google Scholar · View at Scopus
  12. H. M. Massey and A. M. Flanagan, “Human osteoclasts derive from CD14-positive monocytes,” British Journal of Haematology, vol. 106, no. 1, pp. 167–170, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. V. Shalhoub, G. Elliott, L. Chiu et al., “Characterization of osteoclast precursors in human blood,” British Journal of Haematology, vol. 111, no. 2, pp. 501–512, 2000. View at Publisher · View at Google Scholar
  14. N. Nakagawa, M. Kinosaki, K. Yamaguchi et al., “RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis,” Biochemical and Biophysical Research Communications, vol. 253, no. 2, pp. 395–400, 1998. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Hsu, D. L. Lacey, C. R. Dunstan et al., “Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 96, no. 7, pp. 3540–3545, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Kotani, J. Kikuta, F. Klauschen et al., “Systemic circulation and bone recruitment of osteoclast precursors tracked by using fluorescent imaging techniques,” The Journal of Immunology, vol. 190, no. 2, pp. 605–612, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Komano, T. Nanki, K. Hayashida, K. Taniguchi, and M. Nobuyuki, “Identification of a human peripheral blood monocyte subset that differentiates into osteoclasts,” Arthritis Research & Therapy, vol. 8, no. 5, p. R152, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. F. I. L. Clanchy, A. C. Holloway, R. Lari, P. U. Cameron, and J. A. Hamilton, “Detection and properties of the human proliferative monocyte subpopulation,” The Journal of Leukocyte Biology, vol. 79, 757, no. 4, p. 766, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Lari, P. D. Kitchener, and J. A. Hamilton, “The proliferative human monocyte subpopulation contains osteoclast precursors,” Arthritis Research & Therapy, vol. 11, no. 1, article no. R23, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. V. Breuil, H. Schmid-Antomarchi, A. Schmid-Alliana, R. Rezzonico, L. Euller-Ziegler, and B. Rossi, “The receptor activator of nuclear factor (NF)-kappaB ligand (RANKL) is a new chemotactic factor for human monocytes,” The FASEB Journal, vol. 17, no. 12, pp. 1751–1753, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. B. A. Mosheimer, N. C. Kaneider, C. Feistritzer, D. H. Sturn, and C. J. Wiedermann, “Expression and function of RANK in human monocyte chemotaxis,” Arthritis & Rheumatism, vol. 50, no. 7, pp. 2309–2316, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. M. S. Kim, C. J. Day, and N. A. Morrison, “MCP-1 is induced by receptor activator of nuclear factor-κB ligand, promotes human osteoclast fusion, and rescues granulocyte macrophage colony-stimulating factor suppression of osteoclast formation,” The Journal of Biological Chemistry, vol. 280, no. 16, pp. 16163–16169, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. X. Li, L. Qin, M. Bergenstock, L. M. Bevelock, D. V. Novack, and N. C. Partridge, “Parathyroid hormone stimulates osteoblastic expression of MCP-1 to recruit and increase the fusion of pre/osteoclasts,” The Journal of Biological Chemistry, vol. 282, no. 45, pp. 33098–33106, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. X. Yu, Y. Huang, P. Collin-Osdoby, and P. Osdoby, “Stromal cell-derived factor-1 (SDF-1) recruits osteoclast precursors by inducing chemotaxis, matrix metalloproteinase-9 (MMP-9) activity, and collagen transmigration,” Journal of Bone and Mineral Research, vol. 18, no. 8, pp. 1404–1418, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. L. M. Wright, W. Maloney, X. Yu, L. Kindle, P. Collin-Osdoby, and P. Osdoby, “Stromal cell-derived factor-1 binding to its chemokine receptor CXCR4 on precursor cells promotes the chemotactic recruitment, development and survival of human osteoclasts,” Bone, vol. 36, no. 5, pp. 840–853, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Koizumi, Y. Saitoh, T. Minami et al., “Role of CX3CL1/fractalkine in osteoclast differentiation and bone resorption,” The Journal of Immunology, vol. 183, no. 12, pp. 7825–7831, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Ishii, J. G. Egen, F. Klauschen et al., “Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis,” Nature, vol. 458, no. 7237, pp. 524–528, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Ishii, J. Kikuta, Y. Shimazu, M. Meier-Schellersheim, and R. N. Germain, “Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and bone remodeling in vivo,” The Journal of Experimental Medicine, vol. 207, no. 13, pp. 2793–2798, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Kikuta and M. Ishii, “Osteoclast migration, differentiation and function: Novel therapeutic targets for rheumatic diseases,” Rheumatology, vol. 52, no. 2, pp. 226–234, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. Z. Liu, V. Dvornyk, Y. Lu et al., “A novel pathophysiological mechanism for osteoporosis suggested by an in vivo gene expression study of circulating monocytes,” The Journal of Biological Chemistry, vol. 280, no. 32, pp. 29011–29016, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. S. F. Lei, S. Wu, L.-M. Li et al., “An in vivo genome wide gene expression study of circulating monocytes suggested GBP1, STAT1 and CXCL10 as novel risk genes for the differentiation of peak bone mass,” Bone, vol. 44, no. 5, pp. 1010–1014, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. X. D. Chen, P. Xiao, S.-F. Lei et al., “Gene expression profiling in monocytes and SNP association suggest the importance of the gene for osteoporosis in both Chinese and Caucasians,” Journal of Bone and Mineral Research, vol. 25, no. 2, pp. 339–355, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Lu, Y.-Z. Liu, P.-Y. Liu, V. Dvornyk, and H.-W. Deng, “A bootstrap-based regression method for comprehensive discovery of differential gene expressions: An application to the osteoporosis study,” European Journal of Medical Genetics, vol. 54, no. 6, pp. e560–e564, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Xiao, L. Shan, H. Zhu, and F. Xue, “Detection of significant pathways in osteoporosis based on graph clustering,” Molecular Medicine Reports, vol. 6, no. 6, pp. 1325–1332, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Z. Liu, Y. Zhou, L. Zhang et al., “Attenuated monocyte apoptosis, a new mechanism for osteoporosis suggested by a transcriptome-wide expression study of monocytes,” PLoS ONE, vol. 10, no. 2, Article ID e0116792, 2015. View at Publisher · View at Google Scholar · View at Scopus
  36. F. Y. Deng, Y.-Z. Liu, L.-M. Li et al., “Proteomic analysis of circulating monocytes in Chinese premenopausal females with extremely discordant bone mineral density,” Proteomics, vol. 8, no. 20, pp. 4259–4272, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. F. Y. Deng, S. F. Lei, X. D. Chen, L. J. Tan, X. Z. Zhu, and H. W. Deng, “An integrative study ascertained SOD2 as a susceptibility gene for osteoporosis in Chinese,” Journal of Bone & Mineral Research, vol. 26, no. 11, pp. 2695–2701, 2011. View at Google Scholar
  38. F. Y. Deng, S. F. Lei, Y. Zhang, Y. L. Zhang, and Y. P. Zheng, “Peripheral blood monocyte-expressed ANXA2 gene is involved in pathogenesis of osteoporosis in humans,” Molecular & Cellular Proteomics, vol. 10, no. 11, 2011. View at Google Scholar
  39. F.-Y. Deng, W. Zhu, Y. Zeng et al., “Is GSN significant for hip BMD in female Caucasians?” Bone, vol. 63, pp. 69–75, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. L. Zhang, Y.-Z. Liu, Y. Zeng et al., “Network-based proteomic analysis for postmenopausal osteoporosis in Caucasian females,” Proteomics, vol. 16, no. 1, pp. 12–28, 2016. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. Zeng, L. Zhang, W. Zhu et al., “Quantitative proteomics and integrative network analysis identified novel genes and pathways related to osteoporosis,” Journal of Proteomics, vol. 142, pp. 45–52, 2016. View at Publisher · View at Google Scholar
  42. B. Daswani, M. K. Gupta, S. Gavali et al., “Monocyte Proteomics Reveals Involvement of Phosphorylated HSP27 in the Pathogenesis of Osteoporosis,” Disease Markers, vol. 2015, Article ID 196589, 2015. View at Publisher · View at Google Scholar · View at Scopus
  43. B. Daswani, S. Gavali, M. Desai, A. Patil, and M. Ikram Khatkhatay, “Serum levels of phosphorylated heat shock protein 27 (pHSP27) are associated with bone mineral density in pre- & postmenopausal women: A pilot study,” Indian Journal of Medical Research, vol. 143, no. MARCH, pp. 288–296, 2016. View at Publisher · View at Google Scholar · View at Scopus
  44. Y. Wang, L. Li, B. T. Moore et al., “Mir-133a in human circulating monocytes: a potential biomarker associated with postmenopausal osteoporosis,” PLoS ONE, vol. 7, no. 4, Article ID e34641, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. Z. Cao, B. T. Moore, Y. Wang et al., “MiR-422a as a potential cellular microRNA biomarker for postmenopausal osteoporosis,” PLoS ONE, vol. 9, no. 5, Article ID e97098, 2014. View at Publisher · View at Google Scholar · View at Scopus